Topigen Pharmaceuticals Inc. Appoints Jeremy Curnock Cook to Its Board of Directors
MONTREAL--(Marketwire - June 03, 2008) - TOPIGEN Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specialized in developing products for respiratory disorders, today announced the appointment of Jeremy Curnock Cook, MA, to its Board of Directors. Mr. Curnock Cook is Executive Chairman and founder of BioScience Managers Limited (BML).